LB
LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
$42.47 +0.59% (+$0.25)
1M -11.91%
Market Cap $1.22B
P/E Ratio -
Div. Yield -
ROE 25.91%
Piotroski F-Score Weak
2/9Valuation
56 /100
Fair P/B 3.66x
P/E N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 28.07%
Asset turnover 0.00x
ROE 25.91%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 15.08x
Int. coverage N/A
Stability
21 /100
Unstable Beta 0.42x
Profitable years 0
EPS volatility 567.68%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o LBRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Heather D. Turner
Employees
49
Headquarters
New York
Nadchodzące wydarzenia
05 LIS
Earnings
Upcoming earnings report